Monte Rosa Therapeutics, Inc. (GLUE) shares outstanding

Shares outstanding · fiscal 2025
65.54M

Monte Rosa Therapeutics, Inc. (GLUE) had 65.54M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 6.6% higher than the 61.51M of fiscal 2024. Figures as of 18 Nov 2026, 11:49 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
65.54M
Change on fiscal 2024
+6.6%
Highest on record
65.54Mfiscal 2025
Lowest on record
25.00Mfiscal 2021
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Monte Rosa Therapeutics, Inc. shares outstanding, in more detail

The market data feed counts 85.45M shares outstanding today.

Across the 5 fiscal years on record (2021–2025), the highest was 65.54M in fiscal 2025 and the lowest 25.00M in fiscal 2021.

History · 5 fiscal years

Shares outstanding by fiscal year

Monte Rosa Therapeutics, Inc. shares outstanding, year by year

Monte Rosa Therapeutics, Inc. (GLUE) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202565.54M 6.6% up
202461.51M 19.7% up
202351.40M 8.8% up
202247.23M 88.9% up
202125.00M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on GLUE

Monte Rosa Therapeutics, Inc., figure by figure

Monte Rosa Therapeutics, Inc. (GLUE) overview: price, valuation and scorecard

Monte Rosa Therapeutics, Inc. shares outstanding: questions and answers

How many shares does Monte Rosa Therapeutics, Inc. have?

Monte Rosa Therapeutics, Inc. (GLUE) had 65.54M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 6.6% higher than the 61.51M of fiscal 2024. The market data feed counts 85.45M shares outstanding today.

What are the highest and lowest diluted share count figures on record for Monte Rosa Therapeutics, Inc.?

Across the 5 fiscal years on record (2021–2025), the highest was 65.54M in fiscal 2025 and the lowest 25.00M in fiscal 2021.

How is Monte Rosa Therapeutics, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Monte Rosa Therapeutics, Inc. it is on record here for 5 fiscal years, 2021 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Monte Rosa Therapeutics, Inc. (GLUE) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/GLUE/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.